Your ANSwer for Workers' Compensation Medical Cost Containment

Call Us Today!|info@ans-solutions.com
  • drug utilization
    Permalink Gallery

    Government Struggles to Hold Opioid Manufacturers Accountable

Government Struggles to Hold Opioid Manufacturers Accountable

For the first time ever, the U.S. DEA targeted a prescription drug manufacturer for their role in black market opioids and damages incurred. Mallinckrodt Pharmaceuticals, one of the largest national manufacturers of the highly addictive generic painkiller oxycodone, one of the leading drugs responsible for the more than 15,000 overdose deaths in 2015, was accused of shirking its responsibility to report suspicious drug orders.

Who’s to Blame For The Opioid Epidemic?

Created at Mallinckrodt’s Hobart, NY facility, oxycodone shipped via its distributor network, including KeySource, Sunrise Wholesale and Cardinal […]

By |July 24th, 2017|Clinical Alert, Drug Utilization Review, Pharmaceutical Industry|Comments Off on Government Struggles to Hold Opioid Manufacturers Accountable
  • opioid showdown
    Permalink Gallery

    Opioid Showdown: Can States Surpass Federal & Address Big Pharma?

Opioid Showdown: Can States Surpass Federal & Address Big Pharma?

With some states and areas across the country on the receiving end of opioid painkiller prescription shipments that outnumber the people housed therein, state officials are beginning to address the link between the opioid crisis, Big Pharma, and the heavy burden weighing on their municipalities. In an attempt to hold Big Pharma accountable, they’re taking a page out of past lawsuits against tobacco companies – and suing them.

Key Players
Until now, these multibillion dollar companies have been sidelined in the fight against the opioid epidemic. Now they’re being looked at […]

By |July 10th, 2017|Pharmacotherapy Review|Comments Off on Opioid Showdown: Can States Surpass Federal & Address Big Pharma?